Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk | Zendy

Lenard Conradi | Zendy; Hendrik Treede | Zendy; Olaf Franzen | Zendy; Moritz Seiffert | Zendy; Stephan Baldus | Zendy; Johannes Schirmer | Zendy; Thomas Meinertz | Zendy; Hermann Reichenspurner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk

Author(s) -

Lenard Conradi,

Hendrik Treede,

Olaf Franzen,

Moritz Seiffert,

Stephan Baldus,

Johannes Schirmer,

Thomas Meinertz,

Hermann Reichenspurner

Publication year - 2011

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2011.03.007

Subject(s) - medicine , mitraclip , mitral regurgitation , surgery , mitral valve replacement , catheter , mitral valve , mitral valve repair

Conventional or minimally invasive surgical mitral valve repair (MVR) is the gold-standard treatment for severe mitral regurgitation (MR) of any etiology. Given its good safety profile, trans-catheter MVR with the MitraClip™ device is used increasingly for high-risk or inoperable patients. We report our experience with failed MitraClip™ therapy and its impact on subsequent surgical strategies, such as the feasibility of MVR in high-risk patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research